GLP-1 agonists include Liraglutide (Victoza), subcutaneous Semaglutide (Ozempic), Tirzepatide (Wegovy) and Dulaglutide (Trulicity)
While not listed as a direct adverse effect in FDA prescribing information, this cold sensitivity appears linked to the medication's weight loss effects rather than direct temperature regulation changes
Dispose of used syringes and needles immediately in a proper FDA-approved sharps container [12]
For BMI above 40, comparison between GLP-1 therapy and bariatric surgery involves weighing multiple factors including health status, personal preferences, and long-term management considerations
The number on the scale may change but the internal programming that shaped the old weight set point often stays the same
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration